Veru Announces FDA Grant of Fast Track Designation for Sabizabulin for the Treatment of Hospitalized COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome
Stock Information for Veru Inc.
Loading
Please wait while we load your information from QuoteMedia.